Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,179.37
+10.56 (+0.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Delta, Lambda Covid Variants Still Weighing On Market Despite Positive Earnings Reports
August 05, 2021
The market is still in a waiting mode, with a lot hinging on tomorrow’s jobs report. Predictions of a volatile, choppy week in the equity markets did not disappoint on...
Via
Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
August 05, 2021
The Phase 3 trial of Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo in combination with platinum-doublet chemotherapy...
Via
Benzinga
Regeneron Beats Street Estimates Big In Q2 As COVID-19 Antibody Boosts Topline, Cuts FY21 R&D Spend Outlook
August 05, 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned $25.80 per share for the second quarter, beating the $17.69 estimate. It clocked revenue of $5.1 billion,...
Via
Benzinga
Exposures
COVID-19
Regeneron Pharmaceuticals: Q2 Earnings Insights
August 05, 2021
Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) moved higher by 0.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share...
Via
Benzinga
Regeneron Earnings Obliterate Views; Biotech Giant Tops Buy Point
August 05, 2021
Regeneron earnings and sales boomed far above forecasts. The biotech giant rose above a buy point.
Via
Investor's Business Daily
3 Biotech Stocks That Could Make You Richer in August (and Beyond)
August 05, 2021
All three have blockbuster products already on the market.
Via
The Motley Fool
Market Briefing For Tuesday, Aug. 3
August 03, 2021
We do see Tuesday turnaround as a rebound from Monday's just modest fade. Again our wildcard continues to be Covid; and the 'presumed' dovish Fed as relates to 'tapering'.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
10 Biggest Price Target Changes For Monday
August 02, 2021
Raymond James raised Edwards Lifesciences Corporation (NYSE:
Via
Benzinga
FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis
August 02, 2021
Following the June update that
Via
Benzinga
Exposures
COVID-19
Product Safety
Market Briefing For Monday, Aug. 2
August 02, 2021
We're 'not' in a global financial crisis; but we are failing the 'synchronized global recovery', due to the worldwide pandemic.
Via
Talk Markets
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
July 29, 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) have announced topline results from Phase 3 trial evaluating Dupixent (...
Via
Benzinga
Is This Mid-Cap Biotech Stock a Buy Now?
July 29, 2021
This mid-cap growth stock could be a long-term winner.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
Market Briefing For Thursday, July 29
July 29, 2021
Disarming SARS-CoV-2 with pharmaceutical drugs is the 'holy grail' to end the COVID-19 panic, and generally eliminate the panic pressures for vaccines.
Via
Talk Markets
Exposures
COVID-19
3 Things About Regeneron That Smart Investors Know
July 29, 2021
The biotech's COVID-19 antibody cocktail made headlines last year, but there's a bigger story here.
Via
The Motley Fool
Topics
Government
Exposures
COVID-19
Political
3 Reasons Caribou Biosciences Could Be the Best Gene-Editing Stock for Your Portfolio
July 27, 2021
The company has a pedigree and a novel approach that could put it at the top of the CRISPR heap.
Via
The Motley Fool
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Maravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
July 23, 2021
Maravai Lifesciences sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
July 22, 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) started their collaboration in chronic obstructive pulmonary disorder (COPD) to target all...
Via
Benzinga
Alnylam Pharmaceuticals Stock Sees Healthy Rising Relative Strength Rating
July 19, 2021
The Relative Strength (RS) Rating for Alnylam Pharmaceuticals stock climbed into a new percentile Monday, as it got a lift from 63 to 71.
Via
Investor's Business Daily
C4 Therapeutics Stock Enters Leadership Territory
July 19, 2021
A Relative Strength Rating upgrade for C4 Therapeutics shows improving technical performance.
Via
Investor's Business Daily
AMD And Biogen Lead The QQQ Lower Thursday
July 15, 2021
U.S. indices were trading lower Thursday as investors weigh Fed Chair Powell’s comments on inflation to the Senate banking panel. ...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
5 French Stocks To Consider For Bastille Day
July 14, 2021
Bastille Day is France’s National Day, celebrating the Storming of the Bastille on July 14, 1789, a key turning point in the French Revolution. And while the French concept...
Via
Benzinga
Is This Coronavirus Stock Undervalued?
July 14, 2021
This biotech giant might be down, but it isn't out just yet.
Via
The Motley Fool
Exposures
COVID-19
2 Biotech Stocks That are Dirt Cheap Right Now
July 13, 2021
Biotech companies responded to the COVID-19 pandemic in a remarkable way, with vaccinations, treatments, diagnostics, and variant monitoring.
Via
Talk Markets
Exposures
COVID-19
3 Top Biotech Stocks to Buy in July
July 11, 2021
Now's the time to get into these companies while their valuation is still favorable.
Via
The Motley Fool
Is It Too Late to Buy Intellia Therapeutics?
July 10, 2021
After skyrocketing 68% last week, will this stock keep running higher?
Via
The Motley Fool
Here's Why Regeneron Gained 11% Last Month
July 07, 2021
The biopharma outfit dropped news that may mean more for the medicine industry than anybody fully understands.
Via
The Motley Fool
Will an Increase in Vaccinations Hurt Regeneron's COVID Treatment Sales?
July 05, 2021
The antibody cocktail treats people with mild-to-moderate illness.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
This News May Mean Billions for Regeneron
July 05, 2021
Regeneron's COVID-19 treatment is getting easier to administer -- and produce.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.